Sanofi isn’t saying how much it is paying for the OTC rights to Tamiflu in the US, but explained that a successful switch would “support our global cough and cold strategy by expanding into ...

On Friday, Sanofi SA (NASDAQ:SNY ... Opella is the world’s third-largest company in the over-the-counter and vitamins, minerals, and supplements market, serving over 500 million consumers ...

(OTC: CRRFY), Sanofi's sponsorship reflects its aspiration to engage young professionals, particularly those in data management and data science. Sanofi's involvement extends beyond sponsorship ...